Accordingly, Il1r1−/− mice demonstrated both a deficiency in neutrophil recruitment to infected bite sites and were not susceptible to bite-mediated enhancement of virus infection (Figures 6A–6C), identifying this pathway as a putative therapeutic target. This evidence concerns the gene IL1R1 and viral infectious disease.